Glucagon-Like Peptide-1 Receptor Knockout Mice Are Protected from High-Fat Diet-Induced Insulin Resistance
Open accessThe DOI matches its Crossref record; 56 of the 61 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 augments nutrient-stimulated insulin secretion. Chow-fed mice lacking the glucagon-like peptide-1 receptor (Glp1r) exhibit enhanced insulin-stimulated muscle glucose uptake but impaired suppression of endogenous glucose appearance (endoRa). This proposes a novel role for the Glp1r to regulate the balance of glucose disposal in muscle and liver by modulating insulin action. Whether this is maintained in an insulin-resistant state is unknown. The present studies tested the hypothesis that disruption of Glp1r expression overcomes high-fat (HF) diet-induced muscle insulin resistance and exacerbates HF diet-induced hepatic insulin resistance. Mice with a functional disruption of the Glp1r (Glp1r−/−) were compared with wild-type littermates (Glp1r+/+) after12 wk on a regular chow diet or a HF diet. Arterial and venous catheters were implanted for sampling and infusions. Hyperinsulinemic-euglycemic clamps were performed on weight-matched male mice. [3-3H]glucose was used to determine glucose turnover, and 2[14C]deoxyglucose was used to measure the glucose metabolic index, an indicator of glucose uptake. Glp1r−/− mice exhibited increased glucose disappearance and muscle glucose metabolic index on either diet. This was associated with enhanced activation of muscle Akt and AMP-activated protein kinase and reduced muscle triglycerides in HF-fed Glp1r−/− mice. Chow-fed Glp1r−/− mice exhibited impaired suppression of endoRa and hepatic insulin signaling. In contrast, HF-fed Glp1r−/− mice exhibited improved suppression of endoRa and hepatic Akt activation. This was associated with decreased hepatic triglycerides and impaired activation of sterol regulatory element-binding protein-1. These results show that mice lacking the Glp1r are protected from HF diet-induced muscle and hepatic insulin resistance independent of effects on total fat mass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1R is involved in regulating both insulin and glucagon secretion, and its knockout can impair pancreatic function, thereby affecting the balance of these hormones and glucose homeostasis.41,42”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [41]
Citations
Cites
Diet-Induced Type II Diabetes in C57BL/6J Mice
Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A., & Feinglos, M. N. (1988) · Diabetes · doi:10.2337/diab.37.9.1163 · Cited by 1,208
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R., & Schmiegel, W. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 817
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationTissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Hemodynamic actions of insulin
Baron, A. D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e187 · Cited by 608
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Svegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405
Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
Sisley, S., Gutierrez-Aguilar, R., Scott, M., D’Alessio, D. A., Sandoval, D. A., & Seeley, R. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72434 · Cited by 397
Adriaenssens, A. E., Biggs, E. K., Darwish, T., Tadross, J., Sukthankar, T., Girish, M., Polex-Wolf, J., Lam, B. Y., Zvetkova, I., Pan, W., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.013 · Cited by 324
“Similarly, CNO injected at the onset of the dark phase inGiprhypDq mice fed an HFD for 2–4 weeks significantly reduced food intake, but no significant effectwas observed whenCNOwas injected at the start of the light phase (Figures 3D– 3F).”
BackgroundInfluentialWilson-Pérez, H. E., Chambers, A. P., Ryan, K. K., Li, B., Sandoval, D. A., Stoffers, D., Drucker, D. J., Pérez-Tilve, D., & Seeley, R. J. (2013) · Diabetes · doi:10.2337/db12-1498 · Cited by 291
Self-citationTrevaskis, J. L., Griffin, P. S., Wittmer, C., Neuschwander-Tetri, B. A., Brunt, E. M., Dolman, C. S., Erickson, M. R., Napora, J., Parkes, D. G., & Roth, J. D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00476.2011 · Cited by 277
“For example, GLP-1RKO mice challenged with a high-fat diet failed to develop diet-induced obesity and maintained insulin sensitivity, attributable to compensatory increases in energy expenditure associated with increased locomotor activity; however, the precise mechanisms and pathways that regulate this remain to be d…”
BackgroundGLP-1 acts on habenular avoidance circuits to control nicotine intake
Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Yabut, J. M., & Drucker, D. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac018 · Cited by 175
Self-citationNobili, V., Carpino, G., Alisi, A., Franchitto, A., Alpini, G. D., Vito, R. D., Onori, P., Alvaro, D., & Gaudio, E. (2012) · Hepatology · doi:10.1002/hep.25742 · Cited by 160
Kowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154
Campbell, J. E., Müller, T. D., Finan, B., DiMarchi, R. D., Tschöp, M. H., & D’Alessio, D. A. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.010 · Cited by 149
Ussher, J. R., Baggio, L. L., Campbell, J. E., Mulvihill, E. E., Kim, M., Kabir, M. G., Cao, X., Baranek, B. M., Stoffers, D. A., Seeley, R. J., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.04.009 · Cited by 139
Self-citationGut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 127
Kabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
Scott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stancáková, A., Chen, Y., Varga, T. V., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3744 · Cited by 118
Never waste a good crisis: confronting reproducibility in translational research
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.006 · Cited by 117
Self-citationMaternal Exercise Improves Glucose Tolerance in Female Offspring
Stanford, K. I., Takahashi, H., So, K., Alves-Wagner, A. B., Prince, N. B., Lehnig, A. C., Getchell, K. M., Lee, M.-Y., Hirshman, M. F., & Goodyear, L. J. (2017) · Diabetes · doi:10.2337/db17-0098 · Cited by 114
Mabilleau, G., Mieczkowska, A., Irwin, N., Flatt, P. R., & Chappard, D. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0146 · Cited by 106
Varin, E. M., Mulvihill, E. E., Baggio, L. L., Koehler, J. A., Cao, X., Seeley, R. J., & Drucker, D. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.055 · Cited by 104
Self-citationMulvihill, E. E., Varin, E. M., Gladanac, B., Campbell, J. E., Ussher, J. R., Baggio, L. L., Yusta, B., Ayala, J., Burmeister, M. A., Matthews, D., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.007 · Cited by 102
Self-citationKillion, E. A., Lu, S.-C., Fort, M., Yamada, Y., Véniant, M. M., & Lloyd, D. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz002 · Cited by 94
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91
Burmeister, M. A., Ferre, T., Ayala, J. E., King, E. M., Holt, R. M., & Ayala, J. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2011 · Cited by 81
Self-citationNovel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning
Mori, Y., Olaru, A., Cheng, Y., Agarwal, R., Yang, J. P., Luvsanjav, D., Yu, W., Selaru, F. M., Hutfless, S. M., Lazarev, M. G., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0083 · Cited by 80
Williams, D. L., Hyvarinen, N., Lilly, N., Kay, K., Dossat, A., Parise, E., & Torregrossa, A.-M. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.005 · Cited by 78
GLP‐1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Roth, J. D., Erickson, M. R., Chen, S., & Parkes, D. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01537.x · Cited by 74
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H.-W., Cerbone, M., & Dattani, M. T. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 65
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 76
p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine
Krstić, J., Galhuber, M., Schulz, T. J., Schupp, M., & Prokesch, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030921 · Cited by 70
Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats
Krieger, J.-P., Santos da Conceição, E. P., Sanchez-Watts, G., Arnold, M., Pettersen, K. G., Mohammed, M., Modica, S., Lossel, P., Morrison, S. F., Madden, C. J., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00068.2018 · Cited by 63
Nonalcoholic fatty liver disease and atherosclerosis
Gaudio, E., Nobili, V., Franchitto, A., Onori, P., & Carpino, G. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0826-5 · Cited by 67
Naylor, J., Suckow, A. T., Seth, A., Baker, D. J., Sermadiras, I., Ravn, P., Howes, R., Li, J., Snaith, M. R., Coghlan, M. P., et al. (2016) · Biochemical Journal · doi:10.1042/bcj20160476 · Cited by 60
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
Yang, B., Gelfanov, V. M., El, K., Chen, A., Rohlfs, R., DuBois, B., Kruse Hansen, A. M., Perez-Tilve, D., Knerr, P. J., D'Alessio, D., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101638 · Cited by 55
Costford, S. R., Brouwers, B., Hopf, M. E., Sparks, L. M., Dispagna, M., Gomes, A. P., Cornnell, H. H., Petucci, C., Phelan, P., Xie, H., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.012 · Cited by 49
Self-citationKnerr, P. J., Mowery, S. A., Finan, B., Perez-Tilve, D., Tschöp, M. H., & DiMarchi, R. D. (2020) · Peptides · doi:10.1016/j.peptides.2019.170225 · Cited by 49
Dusaulcy, R., Handgraaf, S., Skarupelova, S., Visentin, F., Vesin, C., Heddad-Masson, M., Reimann, F., Gribble, F., Philippe, J., & Gosmain, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1433 · Cited by 48
Liu, D., Pang, J., Shao, W., Gu, J., Zeng, Y., He, H. H., Ling, W., Qian, X., & Jin, T. (2021) · Hepatology · doi:10.1002/hep.31856 · Cited by 48
GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy
Lafferty, R. A., Flatt, P. R., & Irwin, N. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2192865 · Cited by 98
Hypothalamic control of energy and glucose metabolism
Sisley, S. R., & Sandoval, D. A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9189-x · Cited by 50
Cho, Y., Kim, S., Kim, P.-K., Jo, M. J., Park, S.-E., Choi, Y., Jung, S. M., & Kang, H. J. (2025) · Biomolecules · doi:10.3390/biom15020291 · Cited by 50
The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system
Adriaenssens, A. E., Gribble, F. M., & Reimann, F. (2020) · Peptides · doi:10.1016/j.peptides.2019.170194 · Cited by 40
Akarte, A. S., Srinivasan, B. P., & Gandhi, S. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.013 · Cited by 42
Tatarkiewicz, K., Sablan, E. J., Polizzi, C. J., Villescaz, C., & Parkes, D. G. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00495.2013 · Cited by 31
Anderson, E. J. P., Ghamari‐Langroudi, M., Çakır, I., Litt, M. J., Chen, V., Reggiardo, R. E., Millhauser, G. L., & Cone, R. D. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12670 · Cited by 31
Metabolic impact of glucagon deficiency
Hayashi, Y. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01456.x · Cited by 36
On the causes of obesity and its treatment: The end of the beginning
Friedman, J. M. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.026 · Cited by 34
Irwin, N., Gault, V. A., O’Harte, F. P. M., & Flatt, P. R. (2020) · Peptides · doi:10.1016/j.peptides.2019.170203 · Cited by 27
Liu, Z., Yu, S., Jin, X., Sheng, L., Rouzi, M. R. Y., Gao, J., Lü, J., & Lei, T. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s559919 · Cited by 35
Tura, A., Pacini, G., Yamada, Y., Seino, Y., & Åhrén, B. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00288.2018 · Cited by 24
The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour
Perez‐Leighton, C. E., Kerr, B., Scherer, P. E., Baudrand, R., & Cortés, V. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13039 · Cited by 27
GLP-1 physiology and pharmacology along the gut-brain axis
Beutler, L. R. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194744 · Cited by 35
Rafferty, E. P., Wylie, A. R., Hand, K. H., Elliott, C. E., Grieve, D. J., & Green, B. D. (2011) · Biological Chemistry · doi:10.1515/bc.2011.050 · Cited by 22
Melhorn, S. J., Tyagi, V., Smeraglio, A., Roth, C. L., & Schur, E. A. (2014) · Appetite · doi:10.1016/j.appet.2014.07.009 · Cited by 21
Therapeutic Targeting of the GIP Receptor—Revisiting the Controversies
Campbell, J. E., & Drucker, D. J. (2025) · Diabetes · doi:10.2337/db25-0393 · Cited by 22
Self-citationConsidering our methods: Methodological issues with rodent models of appetite and obesity research
Lutz, T. A. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.026 · Cited by 22
Evers, S. S., Shao, Y., Ramakrishnan, S. K., Shin, J. H., Bozadjieva-Kramer, N., Irmler, M., Stemmer, K., Sandoval, D. A., Shah, Y. M., & Seeley, R. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110270 · Cited by 19
Xie, C., Wang, X., Jones, K. L., Horowitz, M., Sun, Z., Little, T. J., Rayner, C. K., & Wu, T. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13906 · Cited by 19
Reed, J., Bain, S. C., & Kanamarlapudi, V. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s415934 · Cited by 24
Krieger, J.-P., Langhans, W., & Lee, S. J. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.037 · Cited by 17
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
Allard, C., Cota, D., & Quarta, C. (2023) · Drugs · doi:10.1007/s40265-023-01982-6 · Cited by 17
Glucagon-Like peptide-1: A new therapeutic target to treat abdominal aortic aneurysm?
Raffort, J., Chinetti, G., & Lareyre, F. (2018) · Biochimie · doi:10.1016/j.biochi.2018.06.026 · Cited by 17
Kumar, N., & D’Alessio, D. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac276 · Cited by 14
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 18
Takagi, Y., Kinoshita, K., Ozaki, N., Seino, Y., Murata, Y., Oshida, Y., & Hayashi, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138322 · Cited by 13
The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells
Bourouh, C., Courty, É., Rolland, L., Pasquetti, G., Gromada, X., Rabhi, N., Carney, C., Moreno, M., Boutry, R., Caron, É., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111170 · Cited by 15
Douros, J. D., Mowery, S. A., & Knerr, P. J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113812 · Cited by 12
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice
McMorrow, H. E., Cohen, A. B., Lorch, C. M., Hayes, N. W., Fleps, S. W., Frydman, J. A., Xia, J. L., Samms, R. J., & Beutler, L. R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186652 · Cited by 12
“To do this, we subjected intake, and that GLP-1R–KO mice and mice treated with GLP-1R antagonists are also protected from obesity (32, 40, 41).”
GLP-1 and Its Role in Glycogen Production: A Narrative Review
Lotosky, J., Jean, X., Altankhuyag, A., Khan, S. R., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. R., & Thanos, P. K. (2025) · Biomedicines · doi:10.3390/biomedicines13071610 · Cited by 17
Murao, N., Seino, Y., Morikawa, R., Hidaka, S., Haraguchi, T., Tomatsu, E., Habara, M., Ohno, T., Yokoi, N., Harada, N., et al. (2025) · The Journal of Physiology · doi:10.1113/jp289067 · Cited by 11
Chen, T., Sun, T., Bian, Y., Pei, Y., Feng, F., Chi, H., Li, Y., Tang, X., Sang, S., Du, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01456 · Cited by 11
Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice
Li, H., Fang, Y., Wang, D., Shi, B., & Thompson, G. J. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00343-w · Cited by 13
Herz, H., Song, Y., Ye, Y., Tian, L., Linden, B., Haija, M. A. E., Chu, Y., Grobe, J. L., Lengeling, R. W., & Mokadem, M. (2021) · Nutrients · doi:10.3390/nu14010120 · Cited by 9
Incretin-Based Therapy for Type 2 Diabetes Mellitus: Pancreatic and Extrapancreatic Effects
Hartman, I., Rojas, E., & Rodríguez-Molina, D. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318235f27d · Cited by 9
Wang, Y., Song, X., Wang, Y., & Wang, N. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.094 · Cited by 6
Regulation of glucose kinetics during exercise by the glucagon‐like peptide‐1 receptor
Burmeister, M. A., Bracy, D. P., James, F. D., Holt, R. M., Ayala, J. E., King, E. M., Wasserman, D. H., Drucker, D. J., & Ayala, J. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.234914 · Cited by 6
Self-citationOvereating: A Conundrum of Lipid Metabolism and Inflammation in Obesity and Cancer
Surumbayeva, A., Saiman, Y., & Astsaturov, I. A. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70104 · Cited by 6
Palmitoylation in cardiometabolic diseases: From molecular mechanisms to clinical implications
Feng, S., Zhou, Y. X., Guo, L., Liang, Y., & Zhu, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107921 · Cited by 7
Antagonistic Effect and In Vitro Activity of Dauricine on Glucagon Receptor
Li, L., Dai, S., Liu, J., Wu, W., Zhao, Q.-X., Wang, X., Wang, N., & Xu, Z. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c00446 · Cited by 5
Gut Factors Mediating the Physiological Impact of Bariatric Surgery
Bethea, M. M., & Sandoval, D. A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01478-9 · Cited by 7
Barron, M., Hayes, H., Fernando, D. G., Geurts, A. M., & Kindel, T. L. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-022-05361-6 · Cited by 3
Medial hypothalamic MC3R signalling regulates energy rheostasis in adult mice
Possa‐Paranhos, I. C., Butts, J., Pyszka, E., Nelson, C., Congdon, S., Cho, D., & Sweeney, P. (2024) · The Journal of Physiology · doi:10.1113/jp286699 · Cited by 6
The function of glucagon-like peptide-1 in the mouse peripheral taste system
Takai, S., Yoshida, R., Yasumatsu, K., Shigemura, N., & Ninomiya, Y. (2015) · Journal of Oral Biosciences · doi:10.1016/j.job.2015.09.002 · Cited by 3
Almohammad, A. A., Aldossari, S. K., Sukumbaji, Z. A., Faden, R. A., Almutairi, M. A., Al-Harbi, N. H., Al-Saaib, M. Y., Almarshedy, B., Alharabi, E., Alhazri, W. A., et al. (2025) · Cureus · doi:10.7759/cureus.95792 · Cited by 10
Yang, W., Hao, C., Wang, N., Xie, J., Zhou, B., Yang, Z., Zheng, A., Wei, J., Li, C., Xie, C., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2661854 · Cited by 3
The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms
Davies, I., Holst, J. J., ROSENKILDE, M. M., & Tan, T. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061824-043740 · Cited by 3
Insulin Sensitivity Initially Worsens but Later Improves With Aging in Male C57BL/6N Mice
Kondo, H., Ono, H., Hamano, H., Sone-Asano, K., Ohno, T., Takeda, K., Ochiai, H., Matsumoto, A., Takasaki, A., Hiraga, C., et al. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad126 · Cited by 3
Lee, G., Lee, H. Y., Lim, Y. J., Kim, J., Rah, S., Chung, M. J., Park, S. Y., Sa, S., Lee, H., Soh, Y., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251399183 · Cited by 1
Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials
Barzgar, H., Darmadi, D., Nafisa, J., Narkulov, S., & Sviridova, M. B. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120772 · Cited by 2
Neuroanatomical dissection of the MC3R circuitry regulating energy rheostasisPreprint
Possa‐Paranhos, I. C., Butts, J., Pyszka, E., Nelson, C., Cho, D., & Sweeney, P. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.22.590573 · Cited by 1
Metabolic Synchronization of the Liver Circadian Clock
Landgraf, D., Drucker, D. J., & Oster, H. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part2.p8.p1-488
Self-citationRegulation of renal brush-border glucose transport in response to metabolic dysregulation
Chichger, H. (2011) · UCL Discovery (University College London)
Hughey, C. C. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25306
Wilson, H. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Metabolic synchronization of the liver circadian clock
Landgraf, D. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1435
Daniels, D., & Mietlicki‐Baase, E. G. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734699055.793554621
Metadata
- Authors
- Ayala, J. E., Bracy, D. P., James, F. D., Burmeister, M. A., Wasserman, D. H., & Drucker, D. J.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Vanderbilt University (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- Ayala, Julio E.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-08-04
- Volume
- 151
- Issue
- 10
- Pages
- 4678-4687
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC2946144
- OpenAlex
- W1978297557
- Cited by
- 95
- References
- 61
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 3 · 2019: 7 · 2018: 9 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 8
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK59637, U24DK059637, R01 DK 54902, R01DK054902)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- GLP-1 receptor, insulin resistance, high-fat diet, muscle glucose uptake, hepatic insulin signaling, Akt, AMPK, hepatic triglycerides, SREBP1, glucose turnover, knockout mice
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Animals, Diet, Atherogenic, Dietary Fats, Female, Glucose, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Sex Characteristics, Receptors, Glucagon, Mice, Knockout, Muscle, Skeletal, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.